Characteristics of fetal anticonvulsant syndrome associated autistic disorder

A D Rasalam, H Hailey, J H G Williams, S J Moore, P D Turnpenny, D J Lloyd, John Dean

Research output: Contribution to journalArticle

252 Citations (Scopus)

Abstract

The aim of this study was to evaluate the clinical features and frequency of autistic disorder or Asperger syndrome (AS; according to Diagnostic and Statistical Manual of Mental Disorders, 4th edition [DSM-IV] criteria) in children exposed to anticonvulsant medication in utero. During a 20-year study period, 626 children were born in Aberdeen to mothers taking antiepileptic drugs (AEDs). The study examined long-term effects of prenatal exposure to AEDs in 260 children (122 males, 138 females). Of these, 26 (16 males) were reported by parents to have social or behavioural difficulties. Eleven children (6 males, 5 females) fulfilled the DSM-IV criteria for autistic disorder and one (female) fulfilled the DSM-IV criteria for AS. These children comprised 4.6% of the exposed children studied, and 1.9% of all exposed children born during the study period. Mean age of these children at diagnosis was 5 years 4 months (SD 2y 11mo) and 9 years 10 months (SD 3y 10mo) at the time of this study. Other children from the group of 26 had difficulties in areas of speech and language development and social communication but did not meet the criteria for an autism spectrum disorder (ASD). Sodium valproate was the drug most commonly associated with autistic disorder, five of 56 (8.9%) of the study children exposed to sodium valproate alone had either autistic disorder or AS. It was concluded that prenatal exposure to anticonvulsant medication is a risk factor for the development of an ASD. Fetal anticonvulsant syndrome associated autistic disorder is characterized by an even sex ratio, absence of regression or skill loss, and language delay in the absence of global delay.

Original languageEnglish
Pages (from-to)551-5
Number of pages5
JournalDevelopmental Medicine and Child Neurology
Volume47
Issue number8
Publication statusPublished - Aug 2005

Fingerprint

Autistic Disorder
Anticonvulsants
Diagnostic and Statistical Manual of Mental Disorders
Valproic Acid
Asperger Syndrome
Language Development Disorders
Language Development
Time and Motion Studies
Sex Ratio
Parents
Communication
Mothers

Keywords

  • Anticonvulsants
  • Asperger Syndrome
  • Autistic Disorder
  • Child
  • Child, Preschool
  • Diagnostic and Statistical Manual of Mental Disorders
  • Epilepsy
  • Female
  • Fetal Diseases
  • Humans
  • Male
  • Mothers
  • Population Surveillance
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Prevalence
  • Syndrome

Cite this

Characteristics of fetal anticonvulsant syndrome associated autistic disorder. / Rasalam, A D; Hailey, H; Williams, J H G; Moore, S J; Turnpenny, P D; Lloyd, D J; Dean, John.

In: Developmental Medicine and Child Neurology, Vol. 47, No. 8, 08.2005, p. 551-5.

Research output: Contribution to journalArticle

@article{2fa925433eed4a3a97a5fd238f8ffdad,
title = "Characteristics of fetal anticonvulsant syndrome associated autistic disorder",
abstract = "The aim of this study was to evaluate the clinical features and frequency of autistic disorder or Asperger syndrome (AS; according to Diagnostic and Statistical Manual of Mental Disorders, 4th edition [DSM-IV] criteria) in children exposed to anticonvulsant medication in utero. During a 20-year study period, 626 children were born in Aberdeen to mothers taking antiepileptic drugs (AEDs). The study examined long-term effects of prenatal exposure to AEDs in 260 children (122 males, 138 females). Of these, 26 (16 males) were reported by parents to have social or behavioural difficulties. Eleven children (6 males, 5 females) fulfilled the DSM-IV criteria for autistic disorder and one (female) fulfilled the DSM-IV criteria for AS. These children comprised 4.6{\%} of the exposed children studied, and 1.9{\%} of all exposed children born during the study period. Mean age of these children at diagnosis was 5 years 4 months (SD 2y 11mo) and 9 years 10 months (SD 3y 10mo) at the time of this study. Other children from the group of 26 had difficulties in areas of speech and language development and social communication but did not meet the criteria for an autism spectrum disorder (ASD). Sodium valproate was the drug most commonly associated with autistic disorder, five of 56 (8.9{\%}) of the study children exposed to sodium valproate alone had either autistic disorder or AS. It was concluded that prenatal exposure to anticonvulsant medication is a risk factor for the development of an ASD. Fetal anticonvulsant syndrome associated autistic disorder is characterized by an even sex ratio, absence of regression or skill loss, and language delay in the absence of global delay.",
keywords = "Anticonvulsants, Asperger Syndrome, Autistic Disorder, Child, Child, Preschool, Diagnostic and Statistical Manual of Mental Disorders, Epilepsy, Female, Fetal Diseases, Humans, Male, Mothers, Population Surveillance, Pregnancy, Prenatal Exposure Delayed Effects, Prevalence, Syndrome",
author = "Rasalam, {A D} and H Hailey and Williams, {J H G} and Moore, {S J} and Turnpenny, {P D} and Lloyd, {D J} and John Dean",
year = "2005",
month = "8",
language = "English",
volume = "47",
pages = "551--5",
journal = "Developmental Medicine and Child Neurology",
issn = "0012-1622",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Characteristics of fetal anticonvulsant syndrome associated autistic disorder

AU - Rasalam, A D

AU - Hailey, H

AU - Williams, J H G

AU - Moore, S J

AU - Turnpenny, P D

AU - Lloyd, D J

AU - Dean, John

PY - 2005/8

Y1 - 2005/8

N2 - The aim of this study was to evaluate the clinical features and frequency of autistic disorder or Asperger syndrome (AS; according to Diagnostic and Statistical Manual of Mental Disorders, 4th edition [DSM-IV] criteria) in children exposed to anticonvulsant medication in utero. During a 20-year study period, 626 children were born in Aberdeen to mothers taking antiepileptic drugs (AEDs). The study examined long-term effects of prenatal exposure to AEDs in 260 children (122 males, 138 females). Of these, 26 (16 males) were reported by parents to have social or behavioural difficulties. Eleven children (6 males, 5 females) fulfilled the DSM-IV criteria for autistic disorder and one (female) fulfilled the DSM-IV criteria for AS. These children comprised 4.6% of the exposed children studied, and 1.9% of all exposed children born during the study period. Mean age of these children at diagnosis was 5 years 4 months (SD 2y 11mo) and 9 years 10 months (SD 3y 10mo) at the time of this study. Other children from the group of 26 had difficulties in areas of speech and language development and social communication but did not meet the criteria for an autism spectrum disorder (ASD). Sodium valproate was the drug most commonly associated with autistic disorder, five of 56 (8.9%) of the study children exposed to sodium valproate alone had either autistic disorder or AS. It was concluded that prenatal exposure to anticonvulsant medication is a risk factor for the development of an ASD. Fetal anticonvulsant syndrome associated autistic disorder is characterized by an even sex ratio, absence of regression or skill loss, and language delay in the absence of global delay.

AB - The aim of this study was to evaluate the clinical features and frequency of autistic disorder or Asperger syndrome (AS; according to Diagnostic and Statistical Manual of Mental Disorders, 4th edition [DSM-IV] criteria) in children exposed to anticonvulsant medication in utero. During a 20-year study period, 626 children were born in Aberdeen to mothers taking antiepileptic drugs (AEDs). The study examined long-term effects of prenatal exposure to AEDs in 260 children (122 males, 138 females). Of these, 26 (16 males) were reported by parents to have social or behavioural difficulties. Eleven children (6 males, 5 females) fulfilled the DSM-IV criteria for autistic disorder and one (female) fulfilled the DSM-IV criteria for AS. These children comprised 4.6% of the exposed children studied, and 1.9% of all exposed children born during the study period. Mean age of these children at diagnosis was 5 years 4 months (SD 2y 11mo) and 9 years 10 months (SD 3y 10mo) at the time of this study. Other children from the group of 26 had difficulties in areas of speech and language development and social communication but did not meet the criteria for an autism spectrum disorder (ASD). Sodium valproate was the drug most commonly associated with autistic disorder, five of 56 (8.9%) of the study children exposed to sodium valproate alone had either autistic disorder or AS. It was concluded that prenatal exposure to anticonvulsant medication is a risk factor for the development of an ASD. Fetal anticonvulsant syndrome associated autistic disorder is characterized by an even sex ratio, absence of regression or skill loss, and language delay in the absence of global delay.

KW - Anticonvulsants

KW - Asperger Syndrome

KW - Autistic Disorder

KW - Child

KW - Child, Preschool

KW - Diagnostic and Statistical Manual of Mental Disorders

KW - Epilepsy

KW - Female

KW - Fetal Diseases

KW - Humans

KW - Male

KW - Mothers

KW - Population Surveillance

KW - Pregnancy

KW - Prenatal Exposure Delayed Effects

KW - Prevalence

KW - Syndrome

M3 - Article

VL - 47

SP - 551

EP - 555

JO - Developmental Medicine and Child Neurology

JF - Developmental Medicine and Child Neurology

SN - 0012-1622

IS - 8

ER -